Kymera Appoints Noah Goodman as Chief Business Officer

Company - People | Apr 09, 2025 | EIN

Kymera Appoints Noah Goodman as Chief Business Officer

Kymera Therapeutics, a biopharmaceutical company from Boston, announced Noah Goodman as the new Chief Business Officer to lead their business development strategy. With extensive experience in the life sciences sector, Goodman has held notable positions at Chroma Medicine, Cadent Therapeutics, Seres Therapeutics, Spark Therapeutics, and Easton Associates. Kymera is known for pioneering targeted protein degradation (TPD) to create medicines for immunological diseases. CEO Nello Mainolfi is confident this new leadership move will support the company’s growth and expanding pipeline. Goodman expressed excitement to join during this crucial phase of development. Founded in 2016, Kymera has set recognition as a leading workplace while deploying solutions for diseases otherwise unresolved by conventional therapeutics.

Sectors

  • Biopharmaceuticals
  • Life Sciences

Geography

  • United States – Kymera Therapeutics is based in Boston, Massachusetts, USA, and operates within the American biopharmaceutical market.

Industry

  • Biopharmaceuticals – Kymera Therapeutics operates in the biopharmaceutical industry, working on groundbreaking treatments for immunological diseases.
  • Life Sciences – The life sciences sector is relevant given Kymera's focus on targeted protein degradation and Noah Goodman's background in this field.

Financials

    Participants

    NameRoleTypeDescription
    Kymera Therapeutics, Inc.Company appointing new CBOCompaniesA clinical-stage biopharmaceutical company focused on developing oral small molecule degrader medicines.
    Noah GoodmanChief Business OfficerPeopleRecently appointed CBO of Kymera Therapeutics with extensive experience in the life sciences sector.
    Chroma MedicinePrevious Employer of Noah GoodmanCompaniesA company where Noah Goodman held senior leadership roles before joining Kymera.
    Cadent TherapeuticsPrevious EmployerCompaniesGoodman worked here as Executive Director before its acquisition by Novartis.
    Seres TherapeuticsPrevious EmployerCompaniesGoodman led collaborations and licensing transactions here.
    Spark TherapeuticsPrevious EmployerCompaniesGoodman worked in the business development department.
    Easton AssociatesPrevious EmployerCompaniesA boutique life sciences consultancy where Goodman served as a management consultant.